OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of genital psoriasis in patients with psoriasis
K.A.P. Meeuwis, Alison Potts Bleakman, P.C.M. van de Kerkhof, et al.
Journal of Dermatological Treatment (2018) Vol. 29, Iss. 8, pp. 754-760
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Piergiorgio Malagoli, Anna Balato, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 2, pp. e2024052-e2024052
Open Access | Times Cited: 17

Psoriasis in special localizations
Klaudia Dopytalska, Piotr Sobolewski, Agata Błaszczak, et al.
Reumatologia/Rheumatology (2018) Vol. 56, Iss. 6, pp. 392-398
Open Access | Times Cited: 93

Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
Marco Galluzzo, Mark S. Talamonti, Arnaldo Cioni, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2631-2631
Open Access | Times Cited: 49

The impact of genital psoriasis on quality of life: a systematic review
Eric Yang, Kristen M. Beck, Isabelle M. Sanchez, et al.
Psoriasis Targets and Therapy (2018) Vol. Volume 8, pp. 41-47
Open Access | Times Cited: 71

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
Alexander Egeberg, Kyoungah See, Alyssa Garrelts, et al.
BMC Dermatology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 69

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis
M. Larsabal, S. Ly, É. Sbidian, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 647-656
Open Access | Times Cited: 68

Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24‐week real‐world study
Teppei Hagino, Marina Onda, Hidehisa Saeki, et al.
The Journal of Dermatology (2024)
Closed Access | Times Cited: 8

Treatment of Genital Psoriasis: A Systematic Review
Kristen M. Beck, Eric Yang, Isabelle M. Sanchez, et al.
Dermatology and Therapy (2018) Vol. 8, Iss. 4, pp. 509-525
Open Access | Times Cited: 51

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3594-3594
Open Access | Times Cited: 44

Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
Diego Orsini, Luigi Gargiulo, Luciano Ibba, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 15

Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey
Joe Gorelick, David Shrom, Kiran Sikand, et al.
Dermatology and Therapy (2019) Vol. 9, Iss. 4, pp. 785-797
Open Access | Times Cited: 39

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3545-3545
Open Access | Times Cited: 11

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, et al.
Acta Dermato Venereologica (2019) Vol. 100, Iss. 1, pp. 1-9
Open Access | Times Cited: 31

Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
Ulrich Mrowietz, Juliet N. Barker, Curdin Conrad, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 2, pp. 348-355
Open Access | Times Cited: 17

Update Vulvadermatologie – Diagnostik und Therapie
Christine Brägelmann, Linn Wölber, Laura Susok, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 65-88
Open Access

Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Dermatology and Therapy (2025)
Open Access

Real‐world 52‐week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index
Teppei Hagino, Marina Onda, Hidehisa Saeki, et al.
The Journal of Dermatology (2025)
Closed Access

Hard-to-Treat Areas in Psoriasis: An Underevaluated Part of the Disease
Adina-Mihaela Lupulescu, A. Savu, Ștefana Bucur, et al.
Life (2025) Vol. 15, Iss. 3, pp. 425-425
Open Access

Genital Psoriasis in Asians: Impact on Quality of Life and Sexual Health
KY Ong, Yee Kiat Heng, Xiahong Zhao, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 3
Closed Access

Genital Psoriasis: Shining Light on This Hidden Disease
Jennifer Clay Cather, Melodie Young, Muriel Boreham, et al.
JEADV Clinical Practice (2025)
Open Access

Psoriasis and sexual dysfunction: links, risks, and management challenges
Gleison Vieira Duarte, Humberto Calmon, Gabriela Radel, et al.
Psoriasis Targets and Therapy (2018) Vol. Volume 8, pp. 93-99
Open Access | Times Cited: 30

Page 1 - Next Page

Scroll to top